- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01837004
Cognitive Regulation Training and Exercise (CORTEX)
Cognitive Regulation Training and Exercise (CORTEX) Trial
Study Overview
Detailed Description
Primary Aim 1: To determine the efficacy of pre-intervention cognitive training for improving exercise adherence and engagement. We hypothesize that class participation rates, physical activity counts, and self-reported exercise participation levels will be higher at 4 months for participants in the CORTEX condition relative to the Control condition. We also predict that pre-intervention training will demonstrate high feasibility/acceptability, as indicated by a thorough process evaluation.
Primary Aim 2: To determine if integrated general and exercise-specific cognitive training improves facets of executive function and exercise-related efficacy judgments. We hypothesize that participants in the CORTEX condition will show faster reaction times and greater accuracy for trained and untrained-domain-relevant tasks, including dual task performance, reasoning, and thought-stopping at post-booster testing and 4-month follow-up. Furthermore, we hypothesize that CORTEX participants will show significantly higher levels of exercise efficacy judgments, and exhibit greater automaticity (faster reaction times) in making those judgments, at post-booster testing, 1 month and 4-month follow-up.
Secondary Aim 1: We will use longitudinal mediation analyses to examine mechanisms of change brought about by the cognitive training effects on exercise adherence and engagement. We hypothesize that changes in efficacy and use of self-regulatory strategies will mediate cognitive training effects on exercise adherence over 4-months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Urbana, Illinois, United States, 61801
- University of Illinois
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- men and women
- between 45-64 years old at time of study
- physically inactive for the past 3 months
- have reliable access to internet
- do NOT own or play exergames (Xbox Kinect, Playstation Move, or Nintendo Wii) regularly
- do NOT engage in "brain-training" regularly
- are NOT enrolled in another exercise program or cognitive training study
- willing to be randomized
- able to participant in the full length of the 5-month study with no more than 2 consecutive weeks of vacation
Exclusion Criteria:
- <45 or >64 years of age at time of study
- physically active (i.e., planned 30-min walking or exercise >2 days/wk)
- do not have reliable access to internet
- own and/or play exergames regularly (e.g., 1 day/wk)
- engage in "brain-training" regularly (e.g., Sudoku or computer game-play 1 day/wk)
- enrolled in another exercise program or cognitive training study
- cognitive impairment as defined by TICS score <21
- depression as defined by Geriatric Depression Scale score >5
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CORTEX
The CORTEX group will attend 10, 2-hour sessions for a period of four weeks prior to the initial exercise program start.
One hour will be devoted to computerized training (stationary dual-task & cognitive control training, self-priming, certainty training) whereas the other hour will be devoted to exergaming involving non-stationary, dual-task training.
|
2-hour sessions for a period of four weeks prior to the initial exercise program start.
One hour will be devoted to computerized training (stationary dual-task & cognitive control training, self-priming, certainty training) whereas the other hour will be devoted to exergaming involving non-stationary, dual-task training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
exercise adherence
Time Frame: 4 months (from exercise intervention baseline to 4-month post-test)
|
|
4 months (from exercise intervention baseline to 4-month post-test)
|
|
exercise program engagement
Time Frame: 4 month period (exercise intervention start to end)
|
|
4 month period (exercise intervention start to end)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
automaticity of exercise-related efficacy judgments
Time Frame: 5-month period
|
-reaction times and interference associated with a novel self-efficacy judgment task; collected at baseline, m1, and m5
|
5-month period
|
|
exercise-related self-efficacy
Time Frame: 5-month period
|
-self-reported confidence in one's ability to adhere to different aspects of the exercise program; collected at baseline, m1, m2, and m5
|
5-month period
|
|
executive functioning
Time Frame: 5-month period
|
-trained and untrained domains of executive functioning (e.g., dual-task ability, inhibitory control, reasoning) and memory assessed via computer-based and pencil-paper tasks; collected at baseline, 1m, and 5m
|
5-month period
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Sean P Mullen, Ph.D., University of Illinois at Urbana-Champaign
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Compliance
-
Baylor Research InstituteCompletedCompliance, Patient | Graft Failure | Heart Transplant RejectionUnited States
-
University of AarhusUnknownPatient Engagement | Patient Empowerment | Patient Compliance
-
HaEmek Medical Center, IsraelUnknownPatient Satisfaction | Patient Compliance
-
VA Office of Research and DevelopmentRecruiting
-
Columbia AsiaCompletedPatient Compliance | Physician-Patient RelationsIndia
-
University of Dublin, Trinity CollegeDublin Dental University HospitalRecruitingCompliance, PatientIreland
-
Aga Khan University Hospital, PakistanCompleted
-
University of Illinois at Urbana-ChampaignNational Institute on Aging (NIA)Completed
-
Coloplast A/SCompletedCompliance, PatientDenmark
-
Arizona State UniversityNational Institute on Drug Abuse (NIDA); Mesa Public SchoolsCompletedPatient ComplianceUnited States
Clinical Trials on CORTEX
-
Catholic University, ItalyMedtronicCompleted
-
HaEmek Medical Center, IsraelRambam Health Care Campus; Technion, Israel Institute of TechnologyNot yet recruiting
-
University of FloridaNational Institute on Aging (NIA); National Center for Advancing Translational... and other collaboratorsCompleted
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedNicotine Withdrawal | Tobacco AbstinenceUnited States
-
Emory UniversityWithdrawn
-
Assistance Publique - Hôpitaux de ParisTerminated
-
Stanford UniversityActive, not recruitingDepressive Disorder, Major | Borderline Personality DisorderUnited States
-
Centre for Addiction and Mental HealthRecruitingAutism Spectrum Disorder | Motor ActivityCanada
-
Università degli Studi dell'InsubriaNot yet recruiting
-
Cairo UniversityCompletedHorizontal Ridge DeficiencyEgypt